UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 3,534	$ 3,024
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	149	163
Amortization	1,646	1,664
Provision for losses on accounts receivable	8	2
Operating Lease, Right-of-Use Asset, Amortization Expense	14	10
Deferred income taxes	(144)	(208)
Stock-based compensation expense	43	41
Tax benefit attributable to exercise of stock options	0	5
Changes in operating assets and liabilities
Accounts receivable and other receivables	(578)	(71)
Inventories	(809)	207
Prepaid expenses and other current assets	(109)	(109)
Accounts payable	695	51
Accrued expenses	597	754
Total adjustments	1,512	2,509
Net cash provided by operating activities	5,046	5,533
CASH FLOWS FROM INVESTING ACTIVITIES
Property and equipment	(237)	(10)
Net cash used in investing activities	(237)	(10)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock - options	19	89
Payment of dividends	0	(1,038)
Net cash provided by/(used in) financing activities	19	(949)
Effect of exchange rate changes on cash	71	(131)
Net increase in cash and cash equivalents	4,899	4,443
Cash at beginning of period	60,974	51,590
Cash at end of period	65,873	56,033
Cash paid during the period for income taxes	82	153
Cash paid during the period for interest	$ 0	$ 0